ArticleJournal of medicinal chemistry2024

Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase Inhibitors.

Florian Wittlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.